Exploring ischemic stroke based on the ferroptosis perspective: ECH1 may serve as a new biomarker and therapeutic target
In this study, taking ferroptosis as an entry point, ECH1 may serve as a potential peripheral blood biomarker and therapeutic target for IS through multidimensional validation, providing a basis for the development of relevant precision diagnostic strategies.
Authors
- Hongxuan Tong (ORCID: https://orcid.org/0000-0003-4788-1768)
- Tao Lu (ORCID: https://orcid.org/0000-0002-8247-8387)
- Haojia Zhang
- Boning Zhang
- Yiyan Zhang (ORCID: https://orcid.org/0000-0001-8270-4500)
- Ke Li (ORCID: https://orcid.org/0009-0000-1697-3323)
- Rendong Qu (ORCID: https://orcid.org/0009-0001-4049-8929)
Institutions
- Beijing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3389/fnins.2025.1622760
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00